NYSE · Healthcare
Bausch & Lomb Corp (BLCO)
As-reported financials and recent SEC filings for Bausch & Lomb Corp, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$5.10B
Net income
$-360.0M
Net margin
-7.1%
Diluted EPS
$-1.02
ROE
-5.5%
P/E (TTM)
—
Market cap
$5.82B
Debt / equity
0.8×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $5.10B | $4.79B | $4.15B | $3.77B | $3.77B |
| Gross profit | — | — | — | — | — |
| Operating income | $113.0M | $162.0M | $130.0M | $207.0M | $329.0M |
| Net income | $-360.0M | $-317.0M | $-260.0M | $6.0M | $182.0M |
| Diluted EPS | $-1.02 | $-0.90 | $-0.74 | $0.02 | $0.52 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-16
View on EDGAR →SD2026-06-01
View on EDGAR →42026-05-28
View on EDGAR →42026-05-28
View on EDGAR →42026-05-28
View on EDGAR →42026-05-28
View on EDGAR →42026-05-28
View on EDGAR →42026-05-28
View on EDGAR →Go deeper on BLCO
Search Bausch & Lomb Corp’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.